----item----
version: 1
id: {523EC4D0-895B-4F75-B66E-92F7B50ED376}
database: master
path: /sitecore/content/ScripIntelligence/Home/Articles/2015/10/23/Etherapeutics Adds New Board Member
parent: {3C066B44-2408-4C2D-939F-7AF55362398E}
name: Etherapeutics Adds New Board Member
master: {00000000-0000-0000-0000-000000000000}
template: {11380B5D-3531-4570-B213-EFC5312266E4}
templatekey: Article

----version----
language: en
version: 1
revision: f4677a1d-589b-4a26-a08e-5e3204598549

----field----
field: {2D750EFF-9058-4ABF-A7FF-57FFE5DA1E3C}
name: Title
key: title
content-length: 37

E-therapeutics Adds New Board Member 
----field----
field: {F1D1DC93-63DF-4AFA-B60F-B3A3E9D36675}
name: Sub Title
key: sub title
content-length: 35

Etherapeutics Adds New Board Member
----field----
field: {446A339B-E1D9-4DE1-8B5E-DB7942EF1723}
name: Body
key: body
content-length: 853

<p>E-Therapeutics PLC. has appointed Trevor Mervyn Jones as non-executive director. Rajesh Chopra will be resigning as non-executive director to return to academic research. Currently Jones is chair of the international clinical research organisation (CRO), Simbec-Orion Group Ltd. and Welsh investment company, Arthurian Life Sciences Ltd. Previously he was director of Allergan Inc. and R&D director of The Wellcome Foundation and has also held advisory and regulatory roles. He was director general of the Association of the British Pharmaceutical Industry (ABPI), board member of the European Federation of Pharmaceutical Industry Associations (EFPIA) and the International Federation of Pharmaceutical Manufacturers Associations (IFPMA). Jones was also a member of the UK government regulatory agency, The Medicines Commission for 12 years. </p><p>
----field----
field: {5BA0578F-65B7-4C22-8233-1603D698D8A4}
name: Summary
key: summary
content-length: 850

<p>E-Therapeutics PLC. has appointed Trevor Mervyn Jones as non-executive director. Rajesh Chopra will be resigning as non-executive director to return to academic research. Currently Jones is chair of the international clinical research organisation (CRO), Simbec-Orion Group Ltd. and Welsh investment company, Arthurian Life Sciences Ltd. Previously he was director of Allergan Inc. and R&D director of The Wellcome Foundation and has also held advisory and regulatory roles. He was director general of the Association of the British Pharmaceutical Industry (ABPI), board member of the European Federation of Pharmaceutical Industry Associations (EFPIA) and the International Federation of Pharmaceutical Manufacturers Associations (IFPMA). Jones was also a member of the UK government regulatory agency, The Medicines Commission for 12 years. </p>
----field----
field: {8F4EE718-6FA0-42A5-85C4-6C8FE8B1FCD4}
name: Navigation Title
key: navigation title
content-length: 35

Etherapeutics Adds New Board Member
----field----
field: {7C4FC796-1311-4DAA-81AC-85EAA2C1C108}
name: Actual Publish Date
key: actual publish date
content-length: 15

20151023T110001
----field----
field: {BDF7C8E1-869E-49FF-B9F5-854B3081A45D}
name: Created Date
key: created date
content-length: 15

20151023T110001
----field----
field: {C926A72A-39DA-446D-B78C-2A650F820A73}
name: Modified Date
key: modified date
content-length: 15

20151023T110001
----field----
field: {1616FE67-7278-4169-948E-C29B00EC8781}
name: Article Number
key: article number
content-length: 8

SC030191
----field----
field: {31603F25-6D9C-4954-BCDE-342E1E184A30}
name: Meta Title Override
key: meta title override
content-length: 37

E-therapeutics Adds New Board Member 
----field----
field: {53288D3D-66D7-4ACE-B3E4-D7D02B1F3672}
name: Referenced Companies
key: referenced companies
content-length: 9

200100809
----field----
field: {5AD65E47-7554-4CE5-87B0-7FB65051C05A}
name: Authors
key: authors
content-length: 38

{202BB75B-8718-40FC-96EC-851DBBB43362}
----field----
field: {AE1BD751-D4E7-49CB-96C4-62E995A06B51}
name: Article Category
key: article category
content-length: 11

expert view
----field----
field: {0F6C8F42-01DC-4E05-B63E-AA25D8AA0E09}
name: Legacy Publication
key: legacy publication
content-length: 38

{0F9CCE10-91C1-4F31-832A-266F482A5DAF}
----field----
field: {5795FF15-0942-41FF-8A77-3B73185F5E1B}
name: Escenic ID
key: escenic id
content-length: 6

361199
----field----
field: {25BED78C-4957-4165-998A-CA1B52F67497}
name: __Created
key: __created
content-length: 16

20160209T042515Z
----field----
field: {5DD74568-4D4B-44C1-B513-0AF5F4CDA34F}
name: __Created by
key: __created by
content-length: 18

sitecore\Anonymous
----field----
field: {8CDC337E-A112-42FB-BBB4-4143751E123F}
name: __Revision
key: __revision
content-length: 36

f4677a1d-589b-4a26-a08e-5e3204598549
----field----
field: {D9CF14B1-FA16-4BA6-9288-E8A174D4D522}
name: __Updated
key: __updated
content-length: 16

20160209T042515Z
----field----
field: {BADD9CF9-53E0-4D0C-BCC0-2D784C282F6A}
name: __Updated by
key: __updated by
content-length: 18

sitecore\Anonymous
